SCD Pharm signs total KRW 700 billion export agreement with U.S. Glenmark

Sam Chun Dang Pharm(CEO Jeon-Kyo Park, SCD Pharm) signed a export agreement of its generic eye drop with U.S. Glenmark on the 20^th. The export agreement is the 2^nd largest export agreement after the last KRW 400 billion agreement with U.S. BPI.

The term of agreement is 10 years after completing a registration process for each product, and they are expecting to generate approximately KRW 700 bi...